Wolverine Stack
Also known as: BPC-157/TB-500 combination, Wolverine blend
BPC-157 + TB-500 | Tissue Repair & Recovery Protocol
Overview
Combines BPC-157 and TB-500 for synergistic tissue repair and recovery. 87.5% improvement in knee pain patients per Lee & Padgett 2021 study.
Key benefits
- Complementary healing mechanisms
- 87.5% improvement in knee pain patients
- Reduced inflammation and enhanced cell migration
- Promotes angiogenesis and reduces scarring
Mechanism of action
BPC-157 increases actin production and modulates nitric oxide for vascular effects; TB-500 sequesters actin for cell migration; synergistic enhancement of fibroblast and immune cell movement to injury sites.
Molecular data
- Type
- Peptide blend
Sequence
N/A
Indications
What the research community uses this compound for, with self-reported effectiveness.
Tissue Repair
Tendon & Ligament Healing
Most effectiveBoth peptides show evidence for accelerated repair; BPC-157 improved Achilles tendon healing in animal models.
Muscle Injury Recovery
Most effectiveBPC-157 demonstrates enhanced muscle regeneration; TB-500 promotes cell migration essential for repair.
Joint Pain & Cartilage
Most effectiveLee & Padgett study showed 87.5% of knee pain patients improved with BPC-157/TB4 combination.
Wound Healing
Accelerated Wound Closure
EffectiveTB-500 Phase 2 trials showed approximately one month faster healing in ulcer patients.
Anti-Inflammatory
Inflammatory Cytokine Reduction
ModerateBoth peptides modulate inflammatory pathways through different mechanisms.
Dosing protocols
Common protocols by delivery method. Adjust the curve below to model accumulation in your own cycle.
Injectable
Subcutaneous injection recommended; most studied and effective route.
| Protocol | Dose | Frequency | Route / duration |
|---|---|---|---|
| General Recovery Protocol | BPC-157: 250mcg 2x/day + TB-500: 2mg 2x/week | BPC-157 daily, TB-500 twice weekly | SubQ |
| Intensive Injury Recovery | BPC-157: 500mcg 2x/day + TB-500: 2.5mg 2x/week | BPC-157 daily, TB-500 twice weekly | SubQ near injury site |
| Maintenance/Prevention Protocol | BPC-157: 250mcg 1x/day + TB-500: 2mg 1x/week | BPC-157 daily, TB-500 weekly | SubQ |
Preparation
You will need
- BPC-157 vial (5mg)
- TB-500 vial (2-5mg)
- Bacteriostatic water
- Insulin syringes (29-31 gauge)
- Alcohol swabs
Steps
- Reconstitute each peptide separately
- BPC-157: Add 2mL BAC water to 5mg vial = 250mcg per 0.1mL
- TB-500: Add 2mL BAC water to 5mg vial = 250mcg per 0.1mL
- Inject slowly along vial wall; swirl gently—never shake
- Store reconstituted peptides refrigerated at 2-8°C
- Do NOT mix peptides in same syringe unless pre-made blend
- Use separate injection sites if administering same day
Work out the water volume and syringe units in the reconstitution calculator →
Oral
BPC-157 stable in gastric acid; TB-500 oral bioavailability less established.
| Protocol | Dose | Frequency | Route / duration |
|---|---|---|---|
| GI Support Protocol | BPC-157: 500mcg-1mg | Once daily on empty stomach | Oral capsule or sublingual |
Interactions
Pairwise interactions with other compounds you might be cycling — the same data behind the cycle builder's safety check.
Chemotherapy Agents
AvoidAngiogenesis promotion could theoretically support tumor growth; contraindicated with cancer history.
NSAIDs
MonitorBPC-157 shows protective effects against NSAID-induced damage; long-term effects unknown.
Corticosteroids
MonitorSteroids may counteract healing; BPC-157 shown to reverse some steroid-induced damage in models.
Anticoagulants
MonitorBoth peptides promote angiogenesis; monitor for bleeding issues.
Growth Hormone (HGH)
SynergisticBPC-157 upregulates GH receptors; combined use may accelerate recovery.
CJC-1295/Ipamorelin
SynergisticGH secretagogues complement stack by increasing endogenous growth hormone.
PEG-MGF
SynergisticMGF activates satellite cells; combined mechanisms may enhance muscle recovery.
GHK-Cu
CompatibleCopper peptide promotes collagen; no negative interactions expected.
Timeline
Typical week-by-week effects reported in clinical and observational data.
- Week 1-2
Possible reduction in acute inflammation and pain at injury sites
- Week 2-4
Noticeable improvement in recovery between workouts; reduced soreness
- Week 4-6
Significant improvement in chronic injuries; improved joint comfort
- Week 6-8
Optimal healing effects; structural improvements in damaged tissues
- Post-Cycle
Benefits may persist as healed tissue maintains integrity
Safety
Reported adverse effects, contraindications, and what to monitor on cycle.
Common side effects
- Not extensively documented in human studies
- Generally well-tolerated in available research
Stop signs — stop and seek advice
- Any unusual lumps, growths, or rapid tissue changes
- Severe injection site reactions or infections
- Signs of allergic reaction (rash, swelling, difficulty breathing)
- Unexpected bleeding or bruising
- Persistent headaches or vision changes
- Any symptoms suggesting abnormal growth
Contraindications
- ANY history of cancer or suspicious growths
- Active malignancy or concurrent chemotherapy
- Pregnancy or breastfeeding
Monitoring
- Tissue growth or changes
- Injection site reactions
- Allergic responses
- Bleeding episodes
- Not FDA approved—research chemical only
- Banned by WADA and major sports organizations
Quality checks
What a legitimate product looks like, what should give pause, and what should make you stop.
Good signs
- White or off-white lyophilized powder cake indicating proper freeze-drying
- Crystal clear solution after reconstitution with bacteriostatic water
- Certificate of Analysis with HPLC purity testing (>98%) and mass spectrometry verification
Warning signs
- Minor clumping acceptable if dissolves completely with gentle swirling
Stop signs — don't use
- Collapsed, yellowed, or powder stuck to vial sides—may indicate degradation from heat
- Persistent cloudiness or visible particles after reconstitution—indicates contamination or degradation
Recent research
Newer papers and trial readouts on file for this compound, with source and date.
2025 · HSS Journal
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
Comprehensive systematic review of 36 studies (1993-2024) confirming BPC-157 enhances GH receptor expression and angiogenesis pathways, with preclinical improvements in muscle, tendon, ligament, and bone injuries.
2025 · Biomedicines
Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing
Narrative review evaluating the regenerative potential and risk profile of BPC-157 for musculoskeletal healing; discusses the gap between promising preclinical results and limited human clinical data.
2016 · Annals of the New York Academy of Sciences
Thymosin Beta-4 Promotes Dermal Healing
Updated review of thymosin beta-4 dermal healing mechanisms including cell migration, angiogenesis, and anti-inflammatory effects in wound models and clinical applications.
References
Primary literature and clinical-trial data informing this entry.
Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain
Lee E, Padgett B · Alternative Therapies in Health and Medicine · 2021
16 patients, intra-articular injection: Overall 87.5% (14/16) experienced knee pain relief. BPC-157 alone: 91.6% improvement (11/12). BPC-157 + TB4 combination: 75% improvement (3/4).
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
Vasireddi A, et al. · HSS Journal · 2025
36 articles reviewed (544 screened, 1993-2024). Preclinical models showed improvements in muscle tears, tendon ruptures, ligament tears, and fracture healing. Mechanism involves enhanced GH receptor expression and angiogenesis.
The Regenerative Peptide Thymosin Beta-4 Accelerates the Rate of Dermal Healing in Preclinical Animal Models and in Patients
Treadwell T, Kleinman HK, Crockford D, Hardy MA, Goldstein AL · Annals of the New York Academy of Sciences · 2012
Two Phase 2 clinical trials of stasis and pressure ulcers showed thymosin beta-4 accelerated wound healing by approximately one month in responsive patients.
Thymosin Beta-4: A Multi-Functional Regenerative Peptide. Basic Properties and Clinical Applications
Goldstein AL, Hannappel E, Sosne G, Kleinman HK · Expert Opinion on Biological Therapy · 2012
Comprehensive review: thymosin beta-4 promotes cell migration, mobilizes stem/progenitor cells, forms new blood vessels, regenerates tissue, and reduces inflammation, apoptosis, and scar formation.
Gastric Pentadecapeptide BPC 157 Accelerates Healing of Transected Rat Achilles Tendon and In Vitro Stimulates Tendocytes Growth
Staresinic M, Petrovic I, Novinscak T, et al. · Journal of Orthopaedic Research · 2003
Rats, 10 mcg/kg i.p. daily, 14 days: BPC-157 fully improved biomechanical properties (load of failure, Young's modulus), functional recovery (Achilles functional index), and histological healing of transected Achilles tendons.
Thymosin Beta-4 Accelerates Wound Healing
Malinda KM, Sidhu GS, Mani H, et al. · Journal of Investigative Dermatology · 1999
Rats, full thickness wounds: topical or intraperitoneal thymosin beta-4 increased re-epithelialization by 42% at 4 days and up to 61% at 7 days, with increased collagen deposition and angiogenesis.
Last updated . How this page was sourced is described in the methodology.